State Street Corp Amends Passive Stake in Arrowhead Pharma
Ticker: ARWR · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 879407
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**State Street Corp still owns a chunk of Arrowhead Pharma, signaling institutional confidence.**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Arrowhead Pharmaceuticals Inc. common stock as of December 31, 2023. This filing indicates that State Street Corp holds a significant, though passive, stake in Arrowhead Pharmaceuticals, which is a pharmaceutical preparations company. For investors, this means a large institutional player sees value in Arrowhead, potentially signaling stability or long-term growth prospects, but it doesn't suggest any active management changes or immediate catalysts.
Why It Matters
This filing shows a major institutional investor, State Street Corp, maintains a significant passive stake in Arrowhead Pharmaceuticals, which can be a vote of confidence for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is an update on a passive institutional ownership stake and does not indicate any immediate risks or changes to the company's operations.
Analyst Insight
An investor should note that State Street Corp's continued passive ownership in Arrowhead Pharmaceuticals Inc. suggests institutional confidence, but this filing alone doesn't provide new catalysts for price movement. It's a routine update on a significant, but non-activist, stake.
Key Players & Entities
- State Street Corp (company) — the entity filing the SC 13G/A, reporting its ownership
- Arrowhead Pharmaceuticals Inc. (company) — the issuer whose common stock is being reported
- December 31, 2023 (date) — the date of the event which required the filing of this statement
- January 24, 2024 (date) — the date the SC 13G/A was filed
FAQ
What type of filing is this and what does 'A' signify?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. The 'A' signifies that it is an 'Amended Filing', meaning it updates previously reported information about beneficial ownership.
Who is the reporting person in this filing?
The reporting person is State Street Corp, a financial institution based in Boston, MA, with a Central Index Key (CIK) of 0000093751.
What company's stock is the subject of this filing?
The subject company, or issuer, is ARROWHEAD PHARMACEUTICALS, INC., a pharmaceutical preparations company located in Pasadena, CA, with a CIK of 0000879407.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as stated on the cover page of the filing.
Under which SEC rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1(B), as indicated by the 'X' next to 'RULE 13D-1 (B)' on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding ARROWHEAD PHARMACEUTICALS, INC. (ARWR).